Detalhe da pesquisa
1.
Association with HLA-DRß1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis.
Hum Mol Genet
; 31(14): 2471-2481, 2022 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094092
2.
Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL dataset.
Clin Exp Rheumatol
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38757292
3.
Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis.
Ann Rheum Dis
; 82(5): 658-669, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564154
4.
Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savings.
Intern Med J
; 2023 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38009675
5.
Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models.
Rheumatology (Oxford)
; 60(4): 1891-1901, 2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33146389
6.
Use of Rescue Therapy with IVIG or Cyclophosphamide in Juvenile Myositis.
Curr Rheumatol Rep
; 23(4): 24, 2021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686540
7.
Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups.
Ann Rheum Dis
; 78(7): 996-1002, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31138531
8.
Impact of next-generation sequencing error on analysis of barcoded plasmid libraries of known complexity and sequence.
Nucleic Acids Res
; 42(16): e129, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25013183
9.
Gene therapy researchers' assessments of risks and perceptions of risk acceptability in clinical trials.
Mol Ther
; 21(4): 806-15, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23337985
10.
Burden of disease and real-world treatment patterns of patients with systemic lupus erythematosus in the Australian OPAL dataset.
Clin Rheumatol
; 42(11): 2971-2980, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407907
11.
The impact of immunocompromise on outcomes of COVID-19 in children and young people-a systematic review and meta-analysis.
Front Immunol
; 14: 1159269, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37691952
12.
Comparative Effectiveness of First-Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set.
ACR Open Rheumatol
; 5(7): 345-353, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308464
13.
Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia.
JAMA Netw Open
; 6(6): e2320851, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382956
14.
Adalimumab or etanercept as first line biologic therapy in enthesitis related arthritis (ERA) - a drug-survival single centre study spanning 10 years.
Semin Arthritis Rheum
; 55: 152038, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35660170
15.
A novel electronic patient-reported outcome delivery system to implement health-related quality of life measures in routine clinical care: An analysis of 5 years of experience.
Front Digit Health
; 4: 1074931, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36698650
16.
JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology.
Pediatr Rheumatol Online J
; 19(1): 146, 2021 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34563217
17.
A survey to understand the feelings towards and impact of COVID-19 on the households of juvenile dermato myositis patients from a parent or carer perspective.
Rheumatol Adv Pract
; 5(3): rkab058, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34541451
18.
Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases.
Med
; 2(9): 1093-1109.e6, 2021 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34414384
19.
Accepting risk in clinical research: is the gene therapy field becoming too risk-averse?
Mol Ther
; 17(11): 1842-8, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19773741
20.
Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients.
Arthritis Res Ther
; 22(1): 79, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32293539